➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

McKinsey
Harvard Business School
Merck
AstraZeneca
Boehringer Ingelheim
Moodys

Last Updated: March 1, 2021

DrugPatentWatch Database Preview

Haloperidol - Generic Drug Details

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

What are the generic sources for haloperidol and what is the scope of patent protection?

Haloperidol is the generic ingredient in six branded drugs marketed by Ortho Mcneil, Ortho Mcneil Pharm, Cycle Pharms Ltd, Duramed Pharms Barr, Innogenix, Lederle, Mylan, Par Pharm, Purepac Pharm, Quantum Pharmics, Royce Labs, Sandoz, SCS, Upsher Smith Labs, Vintage, Watson Labs, Zydus Pharms Usa, Janssen Pharms, Fresenius Kabi Usa, Gland Pharma Ltd, Hospira, Mylan Labs Ltd, Sandoz Inc, Somerset Theraps Llc, Teva Pharms Usa, West-ward Pharms Int, Zydus Pharms, Alpharma, Lannett Co Inc, Morton Grove, Pharm Assoc, Teva, Teva Pharms, Hikma, Abraxis Pharm, Akorn, Baxter Hlthcare Corp, Fosun Pharma, Marsam Pharms Llc, Sagent Pharms, Smith And Nephew, Solopak, and Actavis Mid Atlantic, and is included in one hundred and ten NDAs. Additional information is available in the individual branded drug profile pages.

There are twenty drug master file entries for haloperidol. Seventeen suppliers are listed for this compound.

Drug Prices for haloperidol

See drug prices for haloperidol

Drug Sales Revenue Trends for haloperidol

See drug sales revenues for haloperidol

Recent Clinical Trials for haloperidol

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
InterveXion Therapeutics, LLCPhase 2
HCA Hospice CarePhase 2
University of Alabama at BirminghamN/A

See all haloperidol clinical trials

Pharmacology for haloperidol
Medical Subject Heading (MeSH) Categories for haloperidol

US Patents and Regulatory Information for haloperidol

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Gland Pharma Ltd HALOPERIDOL DECANOATE haloperidol decanoate INJECTABLE;INJECTION 205241-001 May 12, 2017 AO RX No No   Start Trial   Start Trial   Start Trial
Duramed Pharms Barr HALOPERIDOL haloperidol TABLET;ORAL 071220-001 Jul 7, 1987 DISCN No No   Start Trial   Start Trial   Start Trial
Mylan Labs Ltd HALOPERIDOL haloperidol lactate INJECTABLE;INJECTION 078347-001 Sep 14, 2009 AP RX No Yes   Start Trial   Start Trial   Start Trial
Lederle HALOPERIDOL haloperidol TABLET;ORAL 072729-001 Sep 19, 1989 DISCN No No   Start Trial   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Expired US Patents for haloperidol

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Ortho Mcneil HALDOL haloperidol TABLET;ORAL 015921-001 Approved Prior to Jan 1, 1982   Start Trial   Start Trial
Ortho Mcneil HALDOL haloperidol TABLET;ORAL 015921-004 Approved Prior to Jan 1, 1982   Start Trial   Start Trial
Ortho Mcneil HALDOL haloperidol TABLET;ORAL 015921-006 Feb 2, 1982   Start Trial   Start Trial
Ortho Mcneil HALDOL haloperidol TABLET;ORAL 015921-002 Approved Prior to Jan 1, 1982   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >Patent No. >Patent Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Boehringer Ingelheim
Baxter
Merck
AstraZeneca
Harvard Business School
McKinsey

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.